Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
58.00
-1.00 (-1.69%)
Apr 17, 2026, 3:45 PM HKT

HKG:2315 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,585403.85417.66626.62466.45
Short-Term Investments
--7.899.15106.98
Trading Asset Securities
--8.498.2-
Cash & Short-Term Investments
1,585403.85434.04643.97573.42
Cash Growth
292.51%-6.96%-32.60%12.30%-40.11%
Accounts Receivable
300.31229.61142.38107.68103.09
Other Receivables
17.586.936.044.1714.96
Receivables
317.89236.54148.43111.85118.05
Inventory
169.87110.489.923.7321.65
Other Current Assets
75.8765.66130.69139.74161.11
Total Current Assets
2,149816.53723.05919.3874.24
Property, Plant & Equipment
1,2371,2131,4511,5991,391
Long-Term Investments
192.06222.61241.24250.819.69
Other Intangible Assets
52.761.1428.1330.656.06
Long-Term Deferred Tax Assets
0.990.96---
Long-Term Deferred Charges
74.9296.35---
Other Long-Term Assets
18.365.236.16-21.86
Total Assets
3,7242,4152,4492,8002,303
Accounts Payable
135.83115.48175.23146.19102.44
Accrued Expenses
99.3438.0627.8951.6253.66
Short-Term Debt
153.38181.04---
Current Portion of Long-Term Debt
36.2217.58176.84126.67-
Current Portion of Leases
31.9417.8626.3644.9426.9
Current Income Taxes Payable
24.014.514.25.02
Current Unearned Revenue
103.76102.1969.2256.3861.58
Other Current Liabilities
367.8358.6997.56176.06196.96
Total Current Liabilities
930.3534.91577.62606.05446.56
Long-Term Debt
179.88156.13173.9152.17-
Long-Term Leases
182.67197.67167.01191.5162.9
Long-Term Unearned Revenue
82.5484.987.0789.9392.8
Long-Term Deferred Tax Liabilities
--1.9--
Other Long-Term Liabilities
169.52603.1651.48709.36448.55
Total Liabilities
1,5451,5771,6591,6491,051
Common Stock
446.9399.4399.4399.4374.93
Additional Paid-In Capital
3,3452,2181,9921,9921,516
Retained Earnings
-1,573-1,754-1,787-1,404-802.32
Treasury Stock
-45.35-32.76-27.18-18.99-
Comprehensive Income & Other
1.332.69209.09178.32159.03
Total Common Equity
2,175834.06785.891,1461,247
Minority Interest
4.544.554.554.554.76
Shareholders' Equity
2,179838.6790.441,1511,252
Total Liabilities & Equity
3,7242,4152,4492,8002,303
Total Debt
584.09570.28544.11415.2889.8
Net Cash (Debt)
1,001-166.43-110.07228.69483.62
Net Cash Growth
----52.71%-44.82%
Net Cash Per Share
2.49-0.40-0.280.601.33
Filing Date Shares Outstanding
446.9399.4399.4399.4396.69
Total Common Shares Outstanding
446.9399.4399.4399.4374.93
Working Capital
1,218281.62145.43313.25427.68
Book Value Per Share
4.872.091.972.873.33
Tangible Book Value
2,122772.92757.761,1161,241
Tangible Book Value Per Share
4.751.941.902.793.31
Buildings
1,0571,057---
Machinery
506.04442.161,4371,2081,107
Construction In Progress
34.091.735.19268.29181.96
Leasehold Improvements
--240.53161.75166.43
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.